EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic adaptations in antibiotic-resistant Staphylococcus aureus : understanding resistance mechanisms and enhancing antibiotic efficacy

Zhiyu Pan, Wan Zhang, Zhuo Ying Cao, Liting Cai, Yubin Su iD, Jiao Fei iD

Microbiology Spectrum · 04.08.2026 · 14 (8)

DOI: 10.1128/spectrum.00020-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 04.08.2026. Verfasst von Zhiyu Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, The First Affiliated Hospital, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global rise of antibiotic-resistant Staphylococcus aureus represents a serious clinical challenge, contributing substantially to the burden of antimicrobial resistance. This study explores the metabolic mechanisms of antibiotic-resistant S. aureus . Using LC-MS/MS metabolomics, we analyzed laboratory-evolved strains derived from the Newman strain: ciprofloxacin-resistant (R-CIP), cefazolin-resistant (R-CEF), and dual-resistant (R-CC). Metabolomic profiling revealed 41, 57, and 74 differentially abundant metabolites in R-CIP, R-CEF, and R-CC, respectively, with 21 common to all strains. Pathway analysis identified 12, 9, and 10 significantly perturbed pathways in R-CIP, R-CEF, and R-CC, respectively. Three pathways—glycine, serine, and threonine metabolism; alanine, aspartate, and glutamate metabolism; and taurine and hypotaurine metabolism—were consistently dysregulated across all resistant strains. R-CIP uniquely altered butanoate metabolism, while R-CC specifically changed glutamine and purine metabolism. iPath analysis further highlighted suppressed central carbon and energy metabolism as a shared feature of all resistant strains, accompanied by reduced pyruvate dehydrogenase and TCA cycle enzyme activities, as well as decreased cellular NADH, ATP, and reactive oxygen species levels. Supplementation with pyruvate, citrate, or fumarate significantly enhanced the bactericidal effects of ciprofloxacin and cefazolin. These findings demonstrate that S. aureus acquires resistance to ciprofloxacin and cefazolin through downregulation of central carbon and energy metabolism. Exogenous metabolites can potentiate antibiotic efficacy, offering insights into metabolism-targeted strategies to combat antibiotic-resistant S. aureus . IMPORTANCE The global rise of antibiotic-resistant Staphylococcus aureus poses a significant threat to public health, highlighting the urgent need for novel therapeutic strategies. Current understanding of antibiotic resistance mechanisms, particularly at the metabolic level, remains incomplete. This study investigates the metabolic alterations of resistance in S. aureus by analyzing laboratory-evolved strains resistant to ciprofloxacin (R-CIP), cefazolin (R-CEF), and both (R-CC). Through metabolomic profiling, we identified suppressed central carbon and energy metabolism as a shared resistance mechanism, with strain-specific adaptations further complicating the resistance landscape. Notably, supplementation with key metabolites like pyruvate, citrate, and fumarate enhanced antibiotic efficacy, suggesting a promising strategy to combat resistance. These findings provide critical insights into the metabolic vulnerabilities of resistant S. aureus , offering a novel avenue for the development of metabolism-targeted therapies to address the growing challenge of antibiotic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStaphylococcus aureusCiprofloxacinCefazolinMicrobial Sensitivity TestsMetabolomicsStaphylococcal InfectionsDrug Resistance, BacterialHumansTandem Mass Spectrometry

Stichwörter der Autor:innen

antibiotic resistance mechanismcentral carbon metabolismciprofloxacin/cefazolin-resistant S. aureusmetabolic regulation

Substanzen

Anti-Bacterial AgentsCiprofloxacinCefazolin

Autor:innen und Institutionen

  • Department of Blood Transfusion, The First Affiliated Hospital, Jinan University, Guangzhou, China.
  • The Clinical Medical Laboratory Center, The First Affiliated Hospital, Jinan University, Guangzhou, China.
  • MOE Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University) and National Engineering Research Center of Genetic Medicine, MOE Key Laboratory of Tumor Molecular Biology, Guangdong Provi…
  • State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, China.

ORCID-Profile: Yubin Su, Jiao Fei

Zitieren

APA

Pan, Z., Zhang, W., Cao, Z. Y., Cai, L., Su, Y., & Fei, J. (2026). Metabolic adaptations in antibiotic-resistant Staphylococcus aureus : understanding resistance mechanisms and enhancing antibiotic efficacy. Microbiology Spectrum, 14(8). https://doi.org/10.1128/spectrum.00020-26

Vancouver

Pan Z, Zhang W, Cao ZY, Cai L, Su Y, Fei J. Metabolic adaptations in antibiotic-resistant Staphylococcus aureus : understanding resistance mechanisms and enhancing antibiotic efficacy. Microbiology Spectrum. 2026;14(8). doi:10.1128/spectrum.00020-26

BibTeX
@article{Pan2026,
  author = {Pan, Zhiyu and Zhang, Wan and Cao, Zhuo Ying and Cai, Liting and Su, Yubin and Fei, Jiao},
  title = {Metabolic adaptations in antibiotic-resistant Staphylococcus aureus : understanding resistance mechanisms and enhancing antibiotic efficacy},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {8},
  doi = {10.1128/spectrum.00020-26}
}
Kostenlos starten →